The correct answer is B. Yes, because the surface protein in the variant is structurally different from the original virus A protein that was used to design the vaccine.
While some degree of cross-protection may occur due to the immune response, significant changes in the virus's surface proteins (antigens) can lead to decreased effectiveness of the original vaccine against new variants. Thus, updated vaccines may be necessary to ensure adequate protection against these variants.